Pacira BioSciences Inc.

NASDAQ: PCRX · Real-Time Price · USD
24.70
-0.29 (-1.16%)
At close: Aug 15, 2025, 10:02 AM

Pacira BioSciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
700.97M 674.98M 666.82M 541.53M
Cost of Revenue
170.43M 184.67M 199.29M 140.25M
Gross Profit
530.54M 490.31M 467.53M 401.28M
Operating Income
-73.37M 87.67M 60.02M 131.06M
Interest Income
19.69M 11.44M 4.54M 896K
Pretax Income
-63.11M 61.7M 13.3M 56.4M
Net Income
-99.56M 41.95M 15.91M 41.98M
Selling & General & Admin
294.1M 269.44M 254.52M 199.34M
Research & Development
81.58M 76.26M 84.8M 55.55M
Other Expenses
228.23M 56.94M 57.29M 13.55M
Operating Expenses
603.91M 402.63M 396.6M 268.44M
Interest Expense
16.57M 20.31M 39.98M 31.75M
Selling & Marketing Expenses
172.01M 153.04M 145M 111.02M
Cost & Expenses
774.34M 587.3M 595.9M 408.7M
Income Tax Expense
36.45M 19.75M -2.61M 14.42M
Shares Outstanding (Basic)
46.24M 46.22M 45.52M 44.26M
Shares Outstanding (Diluted)
46.24M 51.98M 46.54M 45.63M
EPS (Basic)
-2.15 0.91 0.35 0.95
EPS (Diluted)
-2.15 0.81 0.34 0.92
EBITDA
29.12M 157.58M 144.78M 118.47M
EBIT
-49.67M 79.01M 48.88M 85.4M
Depreciation & Amortization
78.78M 75.57M 91.5M 28.55M